Baxter International Inc
NYSE:BAX

Watchlist Manager
Baxter International Inc Logo
Baxter International Inc
NYSE:BAX
Watchlist
Price: 33.21 USD 0.67% Market Closed
Market Cap: 16.9B USD
Have any thoughts about
Baxter International Inc?
Write Note

Intrinsic Value

The intrinsic value of one BAX stock under the Base Case scenario is 65.62 USD. Compared to the current market price of 33.21 USD, Baxter International Inc is Undervalued by 49%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BAX Intrinsic Value
65.62 USD
Undervaluation 49%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Baxter International Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BAX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BAX?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Baxter International Inc

Provide an overview of the primary business activities
of Baxter International Inc.

What unique competitive advantages
does Baxter International Inc hold over its rivals?

What risks and challenges
does Baxter International Inc face in the near future?

Has there been any significant insider trading activity
in Baxter International Inc recently?

Summarize the latest earnings call
of Baxter International Inc.

What significant events have occurred
in Baxter International Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Baxter International Inc.

Provide P/S
for Baxter International Inc.

Provide P/E
for Baxter International Inc.

Provide P/OCF
for Baxter International Inc.

Provide P/FCFE
for Baxter International Inc.

Provide P/B
for Baxter International Inc.

Provide EV/S
for Baxter International Inc.

Provide EV/GP
for Baxter International Inc.

Provide EV/EBITDA
for Baxter International Inc.

Provide EV/EBIT
for Baxter International Inc.

Provide EV/OCF
for Baxter International Inc.

Provide EV/FCFF
for Baxter International Inc.

Provide EV/IC
for Baxter International Inc.

Show me price targets
for Baxter International Inc made by professional analysts.

What are the Revenue projections
for Baxter International Inc?

How accurate were the past Revenue estimates
for Baxter International Inc?

What are the Net Income projections
for Baxter International Inc?

How accurate were the past Net Income estimates
for Baxter International Inc?

What are the EPS projections
for Baxter International Inc?

How accurate were the past EPS estimates
for Baxter International Inc?

What are the EBIT projections
for Baxter International Inc?

How accurate were the past EBIT estimates
for Baxter International Inc?

Compare the revenue forecasts
for Baxter International Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Baxter International Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Baxter International Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Baxter International Inc compared to its peers.

Compare the P/E ratios
of Baxter International Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Baxter International Inc with its peers.

Analyze the financial leverage
of Baxter International Inc compared to its main competitors.

Show all profitability ratios
for Baxter International Inc.

Provide ROE
for Baxter International Inc.

Provide ROA
for Baxter International Inc.

Provide ROIC
for Baxter International Inc.

Provide ROCE
for Baxter International Inc.

Provide Gross Margin
for Baxter International Inc.

Provide Operating Margin
for Baxter International Inc.

Provide Net Margin
for Baxter International Inc.

Provide FCF Margin
for Baxter International Inc.

Show all solvency ratios
for Baxter International Inc.

Provide D/E Ratio
for Baxter International Inc.

Provide D/A Ratio
for Baxter International Inc.

Provide Interest Coverage Ratio
for Baxter International Inc.

Provide Altman Z-Score Ratio
for Baxter International Inc.

Provide Quick Ratio
for Baxter International Inc.

Provide Current Ratio
for Baxter International Inc.

Provide Cash Ratio
for Baxter International Inc.

What is the historical Revenue growth
over the last 5 years for Baxter International Inc?

What is the historical Net Income growth
over the last 5 years for Baxter International Inc?

What is the current Free Cash Flow
of Baxter International Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Baxter International Inc.

Business Breakdown

Baxter International Inc. is a global healthcare company that has been a trusted name in the medical sector for over eight decades. Founded in 1931, Baxter specializes in lifesaving medical products and therapies, primarily focusing on renal and hospital care. The company's innovations have revolutionized treatment protocols for conditions such as kidney failure, where their dialysis products are vital for patient care. Additionally, Baxter manufactures a diverse range of infusion systems, biosurgery products, and medications, playing a crucial role in surgical and medical environments. With a commitment to improving patient outcomes, Baxter invests heavily in research and development, which...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Baxter International Inc

Current Assets 8.6B
Cash & Short-Term Investments 2.1B
Receivables 2.7B
Other Current Assets 3.8B
Non-Current Assets 17.7B
PP&E 4.8B
Intangibles 11.7B
Other Non-Current Assets 1.1B
Current Liabilities 6.1B
Accounts Payable 1.3B
Accrued Liabilities 2.3B
Other Current Liabilities 2.6B
Non-Current Liabilities 12.5B
Long-Term Debt 10.4B
Other Non-Current Liabilities 2.1B
Efficiency

Earnings Waterfall
Baxter International Inc

Revenue
14B USD
Cost of Revenue
-8.6B USD
Gross Profit
5.4B USD
Operating Expenses
-4.9B USD
Operating Income
449m USD
Other Expenses
-341m USD
Net Income
108m USD

Free Cash Flow Analysis
Baxter International Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q3 2024, Baxter reported a 4% increase in sales to $3.85 billion, outperforming expectations, driven by strong performance in Medical Products & Therapies, particularly with a 7% growth in infusion therapies. Adjusted earnings per share rose 18% to $0.80, exceeding guidance. However, Hurricane Helene is expected to negatively impact Q4 sales by about $200 million, affecting overall 2024 sales growth guidance to 1% to 2%. For continuing operations, Baxter anticipates 2% growth. Looking forward, the company expects 2025 sales growth to return to 4% to 5% and operating margins of 16.5%, aided by improved operational efficiencies.

What is Earnings Call?
Fundamental Scores

BAX Profitability Score
Profitability Due Diligence

Baxter International Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive Free Cash Flow
Positive 3-Years Revenue Growth
48/100
Profitability
Score

Baxter International Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

BAX Solvency Score
Solvency Due Diligence

Baxter International Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average D/E
Average Altman Z-Score
45/100
Solvency
Score

Baxter International Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BAX Price Targets Summary
Baxter International Inc

Wall Street analysts forecast BAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BAX is 38.59 USD with a low forecast of 30.3 USD and a high forecast of 47.25 USD.

Lowest
Price Target
30.3 USD
9% Downside
Average
Price Target
38.59 USD
16% Upside
Highest
Price Target
47.25 USD
42% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BAX?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BAX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BAX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

BAX News

Other Videos

Profile

Baxter International Inc Logo
Baxter International Inc

Country

United States of America

Industry

Health Care

Market Cap

16.9B USD

Dividend Yield

3.49%

Description

Baxter International, Inc. engages in the provision of a portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies, premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software, and services. The company is headquartered in Deerfield, Illinois and currently employs 60,000 full-time employees. The Company’s segments include Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia-Pacific), and Hillrom. The Americas, EMEA and APAC segments provide a portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices and by patients at home under physician supervision.

Contact

ILLINOIS
Deerfield
1 Baxter Pkwy
+18479482000.0
www.baxter.com

IPO

1961-05-15

Employees

60 000

Officers

Chairman of the Board, President & CEO
Mr. Jose E. Almeida
Executive VP, CFO & Interim Chief Accounting Officer
Mr. Joel T. Grade
Executive VP & Group President of Medical Products and Therapies
Ms. Heather Knight
Executive VP & Group President of Pharmaceuticals
Mr. Alok Sonig B.E., Mba
Executive VP & Group President of Kidney Care
Mr. Christopher A. Toth
Senior VP and Chief Medical & Scientific Officer
Ms. Tobi Karchmer M.D., M.S.
Show More
Senior VP & Chief Information Officer
Mr. Charles Rusty Patel
Vice President of Investor Relations
Ms. Clare Trachtman
Executive VP & General Counsel
Mr. David S. Rosenbloom
Senior Vice President, Chief Communications Officer & Corporate Marketing?
Ms. Stacey Eisen
Show Less

See Also

Discover More
What is the Intrinsic Value of one BAX stock?

The intrinsic value of one BAX stock under the Base Case scenario is 65.62 USD.

Is BAX stock undervalued or overvalued?

Compared to the current market price of 33.21 USD, Baxter International Inc is Undervalued by 49%.

Back to Top